Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: Association with disease status

Clinica Chimica Acta

Volumn 331, Issue 1-2, 2003, Pages 37-44

  Evangelopoulos, Dimitrios ^a   Alevizaki, Maria ^a   Lekakis, John ^a   Cimponeriu, Adriana ^a   Papamichael, Christos ^a   Kominakis, Antonios ^b   Kalofoutis, Anastasios ^a   Moutsatsou, Paraskevi ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Coronary artery disease; Estrogen receptor alpha; Gene polymorphism; Mutation; Sex steroids; Vessel

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ANALYSIS; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA ISOLATION; EXON; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HEART BLOOD VESSEL; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INTERNAL CAROTID ARTERY; MALE; METHODOLOGY; MOLECULAR BIOLOGY; MORBIDITY; PARAMETER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUNICA MEDIA;

EID: 12444257725     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00080-9     Document Type: Article

References (43)

1. Baysal K., Losordo D.W. Oestrogen receptors and cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 23(6-7):1996;537-548.
2. Subbiah M.T. Mechanisms of cardioprotection by estrogens. Proc. Soc. Exp. Biol. Med. 217(1):1998;23-29.
3. Jovanović A., Jovanović S. Estrogen and vascular system: more questions for the future. Cardiovasc. Res. 42:1999;9-11.
4. Speir E., Yu Z.X., Takeda K., Ferrans V.J., Cannon R.O. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kB in human coronary smooth muscle cells. Circ. Res. 87:2000;1006-1011.
5. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12(4):2001;152-156.
6. Venkov C.D., Rankin A.B., Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 94:1996;727-733.
7. Haynes M.P., Russell K.S., Bender J.R. Molecular mechanisms of estrogen actions on the vasculature. J. Nucl. Cardiol. 7(5):2000;500-508.
8. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 83:1995;851-857.
9. White R., Parker M.G. Molecular mechanisms of steroid hormone action. Endocr.-Relat. Cancer. 5:1998;1-14.
10. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J.A., Kushner P.J.et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.
11. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A.et al. The oestrogen receptor regulates NF-kB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 67(2):1998;79-88.
12. Miyahara K., Kawamoto T., Sase K., Yui Y., Tuda K., Yang L.X.et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223:1994;719-736.
13. Srivastava S., Weitzmann M.N., Cenci S., Ross F.P., Adler S., Pacifici R. Estrogen decreases. TNF gene expression by blocking JNK activity and the resulting production of C-Jun and Jun D. J. Clin. Invest. 104:1999;503-513.
14. Barbacanne M.A., Rami J., Michel J.B., Souchard J.P., Philippe M., Besombes J.P.et al. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc. Res. 41:1999;672-681.
15. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signalling pathways. Endocr. Rev. 20(4):1999;435-459.
16. Vikenes K., Farstad M., Nordrehaug J.E. Serotonin is associated with coronary artery disease and cardiac events. Circulation. 100(5):1999;483-484.
17. Wissink S., Van Der Burg B., Katzenellenbogen B.S., Van Der Saag P.T. Synergistic activation of the serotonin-1α receptor by nuclear factor-kappa b and estrogen. Mol. Endocrinol. 15(4):2001;543-552.
18. Quaedackers M.E., Van Den Brink C.E., Wissink S., Schreurs R.H.M.M., Gustafsson J.A., Van Der Saag P.T.et al. 4-Hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER) alpha, and not through ER beta. Endocrinology. 142(3):2001;1156-1166.
19. Lehrer S., Sanchez M., Song H.K., Dalton J., Levine E., Savoretti P.et al. Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet. 17:1990;622-624.
20. Lehrer S., Rabin J., Kalir T., Schacter B.S. Estrogen receptor variant and hypertension in women. Hypertension. 21:1993;439-441.
21. Lehrer S.P., Schmutzler R.K., Rabin J.M., Schachter B.S. An estrogen receptor genetic polymorphism and a history of spontaneous abortion-correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Res. Treat. 26:1993;175-180.
22. Taylor J.A., Wilcox A.J., Bowes W.A., Li Y., Liu E.T., You M. Risk of miscarriage and a common variant of the estrogen receptor gene. Am. J. Epidemiol. 137:1993;1361-1364.
23. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B.et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331:1994;1056-1061.
24. Roodi N., Bailey L.R., Kao W.Y., Verrier C.S., Yee C.J., Dupont W.D.et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Inst. 8715:1995;446-451.
25. Kassi E.N., Vlachoyiannopoulos P.G., Moutsopoulos H.M., Sekeris C.E., Moutsatsou P. Molecular analysis of estrogen receptor alpha and beta in lupus patients. Eur. J. Clin. Invest. 31:2001;86-93.
26. Puchner A.M., Tziotis J., Evangelopoulos D., Fountas L., Vlahos G., Creatsas G.et al. Estrogen receptor alpha gene analysis in preeclampsia. Steroids. 66:2001;695-700.
27. Lerman L.S., Silverstein K. Computational stimulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol. 155:1987;482-501.
28. Myers R.M., Maniatis T., Lerman L.S. Detection and localization of single base change by denaturing gradient gel electrophoresis. Methods Enzymol. 155:1987;501-527.
29. Moutsatsou P., Fountas L., Coulocheri S., Kassi E., Sekeris C.E. The oestrogen receptor codon 10 polymorphism detected in breast cancer is also present in non-malignant cells. J. Cancer Res. Clin. Oncol. 125:1999;214-218.
30. Deng H.W., Li J., Li J.L., Dowd R., Davies K.M., Johnson M.et al. Association of estrogen receptor-α genotypes with body mass index in normal healthy postmenopausal Caucasian women. J. Clin. Endocrinol. Metab. 85:2000;2748-2751.
31. Sudhir K., Chou T.M., Chatterjee K., Smith E.P., Williams T.C., Kane J.P.et al. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation. 96:1997;3774-3777.
32. Lewin B. Genes. 1997;700 Oxford Univ. Press, New York. Chapter 23.
33. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
34. Matsubara Y., Murata M., Kawano K., Zama T., Aoki N., Yoshino H.et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler. Thromb. Vasc. Biol. 17:1997;3006-3012.
35. Herrington D.M., Howard T.D., Hawkins G.A., Reboussin D.N., Xu J., Zheng S.L.et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N. Engl. J. Med. 346(13):2002;967-974.
36. Kikuchi T., Hashimoto N., Kawasaki T., Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr. 89(1):2000;42-45.
37. Kunnas T.A., Laippala P., Penttilä A., Lehtimäki T., Karhunen P.J. Association of polymorphism of human a oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ. 321:2000;273-274.
38. Lehtimäki T., Kunnas T.A., Mattila K.M., Perola M., Penttilä A., Koivula T.et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J. Mol. Med. 80:2002;176-180.
39. Fujimmoto J., Hirose R., Ichigo S., Sakaguchi H., Tamaya T. DNA polymorphism in B-domain of the estrogen receptor-alpha among Japanese women. Steroids. 63:1998;146-148.
40. Iafrfati M.D., Karas R.H., Aronovitz M., Kim S., Sullivan T.R., Lubahn D.B.et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3(5):1997;545-548.
41. Karas R.H., Hodgin J.B., Kwoun M., Krege J.H., Aronovitz M., MacKey W.et al. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. PNAS. 96(26):1999;15133-15136.
42. Karas R.H., Schulten H., Pare G., Aronovitz M.J., Ohlsson C., Gustafsson J.-A.et al. Effects of estrogen on the vascular injury response in estrogen receptor α,β (double) knockout mice. Circ. Res. 89(6):2001;534-544.
43. -/- mice. J. Clin. Invest. 107:2001;333-340.